Holen Sie sich die Stockscreener-App
74.31
2.21%
-1.68
Schlusskurs vom Vortag:
$75.99
Offen:
$76.11
24-Stunden-Volumen:
336.39K
Relative Volume:
0.55
Marktkapitalisierung:
$3.73B
Einnahmen:
$379.25M
Nettoeinkommen (Verlust:
$-77.34M
KGV:
-46.09
EPS:
-1.6122
Netto-Cashflow:
$-27.87M
1W Leistung:
-2.30%
1M Leistung:
+14.82%
6M Leistung:
+65.02%
1J Leistung:
+80.67%
1-Tages-Spanne:
$74.26
$76.87
1-Wochen-Bereich:
$73.70
$78.09
52-Wochen-Spanne:
$36.86
$78.09
Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile
Firmenname
Mirum Pharmaceuticals Inc
Sektor
Branche
Telefon
650-667-4085
Adresse
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY
Vergleichen Sie MIRM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MIRM
Mirum Pharmaceuticals Inc
|
74.31 | 3.76B | 379.25M | -77.34M | -27.87M | -1.6122 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-11 | Fortgesetzt | Stifel | Buy |
| 2025-05-19 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-04-17 | Eingeleitet | Stifel | Buy |
| 2023-12-18 | Bestätigt | H.C. Wainwright | Buy |
| 2023-11-20 | Fortgesetzt | JP Morgan | Overweight |
| 2023-11-13 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-10-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-10-17 | Fortgesetzt | Evercore ISI | Outperform |
| 2023-09-20 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2022-09-01 | Eingeleitet | Citigroup | Buy |
| 2021-09-20 | Eingeleitet | JP Morgan | Overweight |
| 2020-08-07 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2020-08-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-07-31 | Eingeleitet | Piper Sandler | Overweight |
| 2020-06-25 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-08-12 | Eingeleitet | Citigroup | Buy |
| 2019-08-12 | Eingeleitet | Evercore ISI | Outperform |
| 2019-08-12 | Eingeleitet | Guggenheim | Buy |
| 2019-08-12 | Eingeleitet | ROTH Capital | Buy |
| 2019-08-12 | Eingeleitet | Raymond James | Outperform |
Alle ansehen
Mirum Pharmaceuticals Inc Aktie (MIRM) Neueste Nachrichten
Woodline Partners LP Acquires 161,867 Shares of Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Adage Capital Partners GP L.L.C. Purchases 195,000 Shares of Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Mirum Pharmaceuticals (NASDAQ:MIRM) Hits New 52-Week HighWhat's Next? - MarketBeat
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Mirum Pharmaceuticals (NASDAQ:MIRM) Sets New 52-Week HighHere's Why - MarketBeat
Eventide Asset Management LLC Sells 79,938 Shares of Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Mirum Pharmaceuticals at Morgan Stanley Conference: Strategic Growth Insights By Investing.com - Investing.com Canada
Mirum Pharmaceuticals announces enrollment completion in the phase 2b Vistas study - MarketScreener
Mirum Pharmaceuticals Announces Enrollment Completion in the Phase 2b VISTAS Study - Business Wire
Published on: 2025-09-08 12:42:47 - beatles.ru
Mirum Pharmaceuticals, Inc. $MIRM Holdings Increased by Frazier Life Sciences Management L.P. - MarketBeat
Multi factor analysis applied to Mirum Pharmaceuticals Inc.Weekly Investment Report & Stock Portfolio Risk Management - Newser
Is Mirum Pharmaceuticals Inc. stock overvalued or fairly priced2025 Geopolitical Influence & Short-Term High Return Ideas - خودرو بانک
Cubist Systematic Strategies LLC Grows Stake in Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Is Mirum Pharmaceuticals Inc. forming bullish engulfing patternsEarnings Trend Report & Safe Entry Trade Signal Reports - خودرو بانک
Can Mirum Pharmaceuticals Inc. reach resistance levels soon2025 EndofYear Setup & Fast Gain Swing Alerts - خودرو بانک
Real time scanner hits for Mirum Pharmaceuticals Inc. explainedBond Market & AI Driven Stock Movement Reports - Newser
Sentiment analysis tools applied to Mirum Pharmaceuticals Inc.2025 Market Trends & Fast Entry Momentum Trade Alerts - Newser
Is Mirum Pharmaceuticals Inc. forming a reversal patternPortfolio Growth Summary & Weekly Top Gainers Trade List - Newser
Published on: 2025-09-05 14:03:50 - Newser
Signal strength of Mirum Pharmaceuticals Inc. stock in tech scannersQuarterly Risk Review & Safe Capital Growth Stock Tips - Newser
Chart overlay techniques for tracking Mirum Pharmaceuticals Inc.Earnings Performance Report & Capital Efficiency Focused Ideas - Newser
Rafferty Asset Management LLC Raises Holdings in Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Will Mirum Pharmaceuticals Inc. stock recover after recent dropMarket Movement Recap & Detailed Earnings Play Alerts - Newser
Using Ichimoku Cloud for Mirum Pharmaceuticals Inc. technicalsQuarterly Profit Summary & Low Drawdown Trading Techniques - Newser
Mirum Pharmaceuticals at Cantor Global: Financial Independence and Growth By Investing.com - Investing.com Canada
Regression analysis insights on Mirum Pharmaceuticals Inc. performanceWeekly Trend Summary & Real-Time Stock Price Movement Reports - Newser
What to do if you’re stuck in Mirum Pharmaceuticals Inc.July 2025 Analyst Calls & Daily Technical Forecast Reports - Newser
What is the next catalyst for Mirum Pharmaceuticals Inc.Trade Risk Report & Safe Capital Growth Stock Tips - خودرو بانک
Mirum Pharmaceuticals stock reaches all-time high of 75.8 USD By Investing.com - Investing.com Australia
Can Mirum Pharmaceuticals Inc. benefit from deglobalization2025 Valuation Update & Weekly Market Pulse Updates - خودرو بانک
What technical models suggest about Mirum Pharmaceuticals Inc.’s comeback2025 Trade Ideas & Expert Verified Stock Movement Alerts - Newser
Kodai Capital Management LP Takes $2.36 Million Position in Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
What indicators show strength in Mirum Pharmaceuticals Inc.2025 Growth vs Value & Fast Exit Strategy with Risk Control - Newser
Can Mirum Pharmaceuticals Inc. sustain its profitabilityMarket Activity Summary & Advanced Technical Signal Analysis - خودرو بانک
Mirum Pharmaceuticals stock reaches all-time high of 75.8 USD - Investing.com
Does Mirum Pharmaceuticals Inc. show high probability of reboundJuly 2025 Spike Watch & Verified Swing Trading Watchlist - Newser
Forecasting Mirum Pharmaceuticals Inc. price range with options dataPortfolio Gains Report & Technical Confirmation Trade Alerts - Newser
Tema Etfs LLC Sells 30,536 Shares of Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Is Mirum Pharmaceuticals Inc. impacted by rising ratesSwing Trade & Real-Time Buy Zone Alerts - خودرو بانک
Is Mirum Pharmaceuticals Inc. showing signs of accumulationMarket Movement Recap & High Accuracy Buy Signal Tips - Newser
Does Mirum Pharmaceuticals Inc. have strong fundamentalsJuly 2025 Breakouts & Risk Managed Investment Strategies - خودرو بانک
How high can Mirum Pharmaceuticals Inc. stock goEarnings Risk Report & Free Real-Time Volume Trigger Notifications - Newser
What are Mirum Pharmaceuticals Inc.’s earnings expectationsPortfolio Growth Summary & High Conviction Buy Zone Alerts - خودرو بانک
Strategies to average down on Mirum Pharmaceuticals Inc.July 2025 Highlights & Free Low Drawdown Momentum Trade Ideas - Newser
Alagille Syndrome Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Takeda, Mirum Pharmaceuticals, Albireo - Barchart.com
How to interpret RSI for Mirum Pharmaceuticals Inc. stockQuarterly Profit Report & Real-Time Volume Analysis - Newser
What indicators show strength in Mirum Pharmaceuticals IncWeekly Trend Report & Capital Efficiency Focused Strategies - Newser
Applying big data sentiment scoring on Mirum Pharmaceuticals Inc.July 2025 Decliners & Fast Entry Momentum Alerts - Newser
Next Century Growth Investors LLC Buys 31,089 Shares of Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Is Mirum Pharmaceuticals Inc. stock forming a triangle pattern2025 Major Catalysts & Advanced Technical Analysis Signals - خودرو بانک
Finanzdaten der Mirum Pharmaceuticals Inc-Aktie (MIRM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):